Clinical Trial Results

Showing: All studies [change]
Condition: Diabetes Location: Fleming Island, Florida 25 trials found
New Search
Filter
Trial Phase
Study Type
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
PHASE3INTERVENTIONAL Fairhope, Alabama +4 more
RECRUITING
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
PHASE2INTERVENTIONAL San Dimas, California +4 more
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
PHASE3INTERVENTIONAL Sun City, Arizona +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Wearable Sensory Prosthesis to Improve Coordination, Walking, and Physical Activity
NAINTERVENTIONAL Jacksonville, Florida
RECRUITING
Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients
NAINTERVENTIONAL Jacksonville, Florida
RECRUITING
Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families
NAINTERVENTIONAL Jacksonville, Florida +1 more
RECRUITING
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NAINTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Inpatient Use of Personal Continuous Glucose Monitor (CGM) to Improve Diabetes Mellitus Control
NAINTERVENTIONAL Jacksonville, Florida
RECRUITING
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
PHASE2INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes
N/AOBSERVATIONAL Jacksonville, Florida +1 more
RECRUITING
Registry for Stage 2 Type 1 Diabetes
N/AOBSERVATIONAL Los Angeles, California +4 more
RECRUITING
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
PHASE3INTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
N/AOBSERVATIONAL Jacksonville, Florida +1 more
RECRUITING
A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the Body
PHASE1INTERVENTIONAL Santa Ana, California +2 more
RECRUITING
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
PHASE1, PHASE2INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type